Vogenx Inc.

Vogenx Inc.

VOGX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$128.4M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Vogenx Inc.Vogenx Inc.-31.5--8%--
$-0.01

Current Fair Value

100.1% downside

Overvalued by 100.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$128.40 Million
Enterprise Value$123.27 Million
Earnings per Share$-0.1
Beta0
Outstanding Shares10,404,831

Return

Return on Equity-7.66%ROE
Return on Assets-7.58%
Return on Invested Capital-3.73%

Valuation & Multiples

P/E Ratio-31.48P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio1.76Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-40.35
Enterprise Value to Net Income-20
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 6, 2026
EPS
-$0.14
Est. -$0.07
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
December 17, 2026
EPS Estimate
-$0.15
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Vogenx Inc.

4 employees
CEO: James Green

Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglyc...

Vogenx Insider Information FAQ

Stockcircle tracks 1 top investor with a current 13F position in Vogenx. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.